title: A postmenopausal osteoporotic woman losing bone mineral density despite bisphosphonates.
abstract: Bisphosphonates are pyrophosphate analogues, with a strong affinity for bones. They inhibit bone resorption and are currently the first choice of treatment for osteoporosis. Bisphosphonates should be taken in a specific manner and for at least one year to be effective in the maintenance and improvement of bone mineral density (BMD), as well as for protection against fractures. We report a case of a postmenospausal osteoporotic woman who lost BMD despite being on bisphosphonate therapy for eight years, highlighting issues that a primary care doctor needs to address before deciding on the next best option.
authors.affiliation: A case report of a postmenopausal osteoporotic woman losing bone mineral density after 8 years of being on bisphosphonates.
authors.forename: Psm
authors.initials: P
authors.lastname: Lai
authors.affiliation: A case report of a postmenopausal osteoporotic woman losing bone mineral density after 8 years of being on bisphosphonates.
authors.forename: T
authors.initials: T
authors.lastname: Nagammai
authors.affiliation: A case report of a postmenopausal osteoporotic woman losing bone mineral density after 8 years of being on bisphosphonates.
authors.forename: Sr
authors.initials: S
authors.lastname: Vethakkan
keywords: bisphosphonate; bone mineral density; osteoporosis; postmenopausal